Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.43T
1-Year Return 25.4%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Quarter Return
+3.09%
1 Year Return
+25.4%
3 Year Return
+109.59%
5 Year Return
+197.61%
10 Year Return
+489.39%
AUM
$184B
AUM Growth
+$184B
Cap. Flow
+$1.09B
Cap. Flow %
0.59%
Top 10 Hldgs %
15.06%
Holding
4,221
New
95
Increased
2,386
Reduced
984
Closed
126

Sector Composition

1 Healthcare 14.47%
2 Technology 14.13%
3 Financials 13.83%
4 Industrials 10.15%
5 Consumer Discretionary 9.32%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EVRI
3251
DELISTED
Everi Holdings
EVRI
$388K ﹤0.01%
337,549
-68,024
-17% -$78.2K
ADVM icon
3252
Adverum Biotechnologies
ADVM
$69.5M
$386K ﹤0.01%
12,237
+2,719
+29% +$85.8K
VMEM
3253
DELISTED
VIOLIN MEMORY, INC.
VMEM
$386K ﹤0.01%
105,172
-23,041
-18% -$84.6K
TNK icon
3254
Teekay Tankers
TNK
$1.79B
$384K ﹤0.01%
16,120
+3,394
+27% +$80.9K
CTIC
3255
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$384K ﹤0.01%
113,158
-18,950
-14% -$64.3K
NAVB
3256
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$382K ﹤0.01%
36,010
-5,278
-13% -$56K
MSD
3257
Morgan Stanley Emerging Markets Debt Fund
MSD
$152M
0
-$264
SALM
3258
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$378K ﹤0.01%
52,382
+10,795
+26% +$77.9K
AMPE
3259
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$378K ﹤0.01%
978
+220
+29% +$85K
OCUL icon
3260
Ocular Therapeutix
OCUL
$2.27B
$377K ﹤0.01%
76,212
+5,816
+8% +$28.8K
NVTR
3261
DELISTED
Nuvectra Corporation Common Stock
NVTR
$377K ﹤0.01%
50,948
-4,194
-8% -$31K
HBIO icon
3262
Harvard Bioscience
HBIO
$20M
$375K ﹤0.01%
131,332
-37,302
-22% -$107K
AGU
3263
DELISTED
Agrium
AGU
$375K ﹤0.01%
4,153
+7
+0.2% +$632
CDTX icon
3264
Cidara Therapeutics
CDTX
$1.61B
$373K ﹤0.01%
1,812
+461
+34% +$94.9K
NGL icon
3265
NGL Energy Partners
NGL
$748M
$373K ﹤0.01%
19,356
+3,682
+23% +$71K
ARCC icon
3266
Ares Capital
ARCC
$15.8B
$372K ﹤0.01%
26,205
+2
+0% +$28
XRM
3267
DELISTED
Xerium Technologies Inc (new)
XRM
$371K ﹤0.01%
58,265
-10,866
-16% -$69.2K
TCFC
3268
DELISTED
The Community Financial Corporation Common Stock
TCFC
$370K ﹤0.01%
16,726
TSQ icon
3269
Townsquare Media
TSQ
$115M
$369K ﹤0.01%
46,824
+1,846
+4% +$14.5K
PAMT
3270
PAMT CORP Common Stock
PAMT
$253M
$369K ﹤0.01%
93,092
+7,108
+8% +$28.2K
SYNC
3271
DELISTED
Synacor, Inc.
SYNC
$369K ﹤0.01%
120,048
+32,789
+38% +$101K
ASYS icon
3272
Amtech Systems
ASYS
$116M
$368K ﹤0.01%
61,752
WLDN icon
3273
Willdan Group
WLDN
$1.48B
$368K ﹤0.01%
34,711
SIOX
3274
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$366K ﹤0.01%
3,566
+1,716
+93% +$176K
OAKS
3275
DELISTED
Five Oaks Investment Corp.
OAKS
$366K ﹤0.01%
66,937